395
Views
25
CrossRef citations to date
0
Altmetric
Original Research

Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi

, , , , , , & show all
Pages 97-113 | Published online: 03 May 2011

References

  • BurgdorferWBarbourAGHayesSFBenachJLGrunwaldtEDavisJPLyme disease-a tick-borne spirochetosis?Science1982216131713197043737
  • StrickerRBJohnsonLLyme disease: the next decadeInfect Drug Resist201141921694904
  • Van DamAPKuiperHVosKDifferent genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosisClin Infect Dis1993177087177903558
  • StrickerRBJohnsonLLyme disease diagnosis and treatment: lessons from the AIDS epidemicMinerva Med201010141942521196901
  • BaconRMKugelerKJMeadPSfor the Centers for Disease Control and Prevention (CDC)Surveillance for Lyme disease – United States, 1992–2006MMWR Surveill Summ2008571918830214
  • MeekJIRobertsCLSmithEVCartterMLUnderreporting of Lyme disease by Connecticut physicians, 1992J Public Health Manag Pract19962616510186700
  • BoltriJMHashRBVogelRLPatterns of Lyme disease diagnosis and treatment by family physicians in a southeastern stateJ Community Health20022739540212458782
  • LiegnerKBShapiroJRRamsayDHalperinAJHogrefeWKongLRecurrent erythema migrans despite extended antibiotic treatment with minocycline in a patient with persisting Borrelia burgdorferi infectionJ Am Acad Dermatol1993282 Pt 23123148436647
  • DontaSTTetracycline therapy for chronic Lyme diseaseClin Infect Dis199725Suppl 1S52S569233665
  • DontaSTMacrolide therapy of chronic Lyme diseaseMed Sci Monit20039136142
  • KrausePJFoleyDTBurkeGSChristiansonDClosterLSpielmanAReinfection and relapse in early Lyme diseaseAm Trop Med Hyg20067510901094
  • HodzicEFengSHoldenKFreetKBartholdSWPersistence of Borrelia burgdorferi following antibiotic treatment in miceAntimicrob Agents Chemother2008521728173618316520
  • StraubingerRKPCR-based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-day post-infection periodJ Clin Microbiol2000382191219910834975
  • OksiJMarjamakiMNikoskelainenJViljanenMKBorrelia burg-dorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosisAnn Med19993122523210442678
  • GeYLiCCorumLSlaughterCACharonNWStructure and expression of the FlaA periplasmic flagellar protein of Borrelia burgdorferiJ Bacteriol1998180241824259573194
  • SalMSLiCMotalabMAShibataSAizawaSCharonNWBorrelia burgdorferi uniquely regulates its motility genes and has an intricate fla-gellar hook-basal body structureJ Bacteriol20081901912192118192386
  • LivengoodJAGilmoreRJInvasion of human neuronal and glial cells by an infectious strain of Borrelia burgdorferiMicrobes Infect200682832284017045505
  • WuJWeeningEHFaskeJBHöökMSkareJTInvasion of eukaryotic cells by Borrelia burgdorferi requires β1 integrins and Src kinase activityInfect Immun2011791338134821173306
  • AlbanPSJohnsonPWNelsonDRSerum-starvation-induced changes in protein synthesis and morphology of Borrelia burgdorferiMicrobiology200014611912710658658
  • RamamoorthyRScholl-MeekerDBorrelia burgdorferi proteins whose expression is similarly affected by culture temperature and pHInfect Immun2001692739274211254645
  • MurgiaRCincoMInduction of cystic forms by different stress conditions in Borrelia burgdorferiAPMIS2004112576214961976
  • BrorsonØBrorsonSHIn vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H mediumInfection1998261441509646104
  • BrorsonØBrorsonSHTransformation of cystic forms of Borrelia burg-dorferi to normal mobile spirochetesInfection1997252402469266264
  • Al-RobaiySDihaziHKaczaJMetamorphosis of Borrelia burgdorferi organisms – RNA, lipid and protein composition in context with the spirochetes’ shapeJ Basic Microbiol201050Suppl 1S5S1720967786
  • KerstenAPoitschekCRauchSAbererEEffects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferiAntimicrob Agents Chemother199539112711337625800
  • SapiEMacDonaldABiofilms of Borrelia burgdorferi in chronic cutaneous borreliosisAm J Clin Pathol2008129988989
  • EisendleKMüllerHZelgerBBiofilms of Borrelia burgdorferi in chronic cutaneous borreliosisAm J Clin Pathol2008129989990
  • JefferesonKKWhat drives bacteria to form a biofilm?FEMS Microbiol Lett200452917924
  • StewartPCostertonJWAntibiotic resistance of bacteria in biofilmsLancet200135813513811463434
  • CostertonJWStewartPSGreenburgEPBacterial biofilms, a common cause of persistent infectionsScience19992841318132210334980
  • HunfeldKPKraiczyPKekoukhESchäferVBradeVStandardized in vitro susceptibility testing of Borrelia burgdorferi against well-known and newly developed antimicrobial agents – possible implications for new therapeutic approaches to Lyme diseaseInt J Med Microbiol2002291Suppl 3312513712141737
  • DeverLLJorgensenJHBarbourAGIn vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a micro-dilution MIC method and time-kill studiesJ Clin Microbiol199230269226971400969
  • BoernerJFailingKWittenbrinkMMIn vitro antimicrobial susceptibility testing of Borrelia burgdorferi: influence of test conditions on minimal inhibitory concentration (MIC) valuesZentralbl Bakteriol199528349609810645
  • SiegemundMvan BommelJInceCAssessment of regional tissue oxygenationIntensive Care Med1999251044106010551958
  • VenkateshBMorganTJLipmanJSubcutaneous oxygen tensions provide similar information to ileal luminal CO2 tensions in an animal model of hemorrhagic shockIntensive Care Med20002659260010923735
  • Ruzic-SabljicEStrleFComparison of growth of Borrelia afzelii, B. garinii, and B. burgdorferi sensu stricto in MKP and BSK-II mediumInt J Med Microbiol200429440741215595391
  • WangGIyerRBittkerSVariations in Barbour-Stoenner-Kelly culture medium modulate infectivity and pathogenicity of Borrelia burgdorferi clinical isolatesInfect Immun2004726702670615501807
  • BrorsonØBrorsonSHAn in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to tinidazoleInternational Microbiol20047139142
  • BrorsonØBrorsonSHScythesJMacAllisterJWierAMargulisLDestruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecyclineProc Natl Acad Sci U S A2009106186561866119843691
  • MazzeiTMiniENovelliAPeritiPChemistry and mode of action of macrolidesJ Antimicrob Chemother199331Suppl C197683018
  • ChopraIRobertsMTetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistanceMicrobiol Mol Biol Rev20016523226011381101
  • TensonTLovmarMEhrenbergMThe mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosomeJ Mol Biol20033301005101412860123
  • KasbekarNAcharyaPSTelithromycin: the first ketolide for the treatment of respiratory infectionsAm J Health Syst Pharm20056290591615851496
  • GoldmanPThe development of 5-nitroimidazoles for the treatment and prophylaxis of anaerobic bacterial infectionsJ Antimicrob Chemother19821023336749793
  • SloverCMRodvoldKADanzigerLHTigecycline: a novel broad-spectrum antimicrobialAnn Pharmacother20074196597217519296
  • BartholdSWHodzicEImaiDMFengSYangXLuftBJIneffectiveness of tigecycline against persistent Borrelia burgdorferiAntimicrob Agents Chemother20105464365119995919